AGCJ
HALO icon

Alden Global Capital (Jersey)’s Halozyme HALO Stock Holding History

Alden Global Capital (Jersey)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-332,500
Closed -$3.21M – 12
2014
Q4 		$3.21M Buy
+332,500
New +$2.95M 0.77% 33

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alden Global Capital (Jersey)'s HALO Position: Q1 2015 in Review

Alden Global Capital (Jersey) sold out of Halozyme (HALO) in Q1 2015, closing a stake of 332,500 shares — an estimated $3.21M sold.

Alden Global Capital (Jersey) first reported a position in HALO in Q4 2014 and held it in 1 quarter. The position peaked at $3.21M in Q4 2014. 137 funds tracked by Wall St. Rank hold HALO as of Q1 2015.

  • Alden Global Capital (Jersey) reported no remaining Halozyme position as of Q1 2015 after selling out during the quarter.
  • Alden Global Capital (Jersey) sold 332,500 Halozyme shares in Q1 2015, an estimated $3.21M.
  • Alden Global Capital (Jersey) first reported a position in Halozyme in Q4 2014 and held it in 1 quarter.
  • Alden Global Capital (Jersey)'s Halozyme position peaked at $3.21M in Q4 2014.
  • 137 funds tracked by Wall St. Rank held Halozyme as of Q1 2015.

Based on Alden Global Capital (Jersey)'s 13F filing for Q1 2015.